Navigation Links
TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
Date:9/10/2007

LA JOLLA, Calif., Sept. 10 /PRNewswire-FirstCall/ -- TorreyPines Therapeutics, Inc. (Nasdaq: TPTX) today announced completion of its third Phase I clinical trial for NGX267, in clinical development for the treatment of cognitive impairment associated with schizophrenia (CIAS). The compound, a functionally selective muscarinic (M1) agonist, was found to be safe and well-tolerated when given orally to healthy male volunteers once-daily for four consecutive days. In two previous Phase I trials, NGX267, administered as single oral doses, was shown to be well-tolerated in healthy young adult males, as well as in healthy elderly males and females.

The purpose of the Phase I trial was to investigate the safety, tolerability and pharmacokinetics of multiple doses of NGX267 and to confirm data from previous studies in which NGX267 demonstrated evidence of muscarinic receptor stimulation as measured by increases in salivary flow. A total of 60 healthy males, between the ages of 18 and 55, were enrolled in the double-blind, placebo-controlled trial conducted at one center in Belgium. In a series of sequential dosing cohorts, subjects received a single oral dose of either 10, 20, 30 or 35 mg of NGX267 once-daily for four consecutive days. NGX267 was well tolerated at doses up to and including 30 mg, a dose range believed to be effective for treating memory and cognitive disturbances. TorreyPines plans to initiate a Phase II dose-ranging trial in CIAS during the first half of 2008.

A secondary objective was to obtain quantitative measures of salivary flow, prior to and at multiple time points post-dosing, as a peripheral biomarker for stimulation of the muscarinic receptor. In the study, increases in peak and total sal
'/>"/>

SOURCE TorreyPines Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
2. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
3. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
4. GTC Biotherapeutics to Webcast Corporate Presentation at the C.E. Unterberg, Towbin Emerging Growth Life Opportunities Conference
5. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
6. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
7. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
8. Pieris Progresses Development of its Proprietary Biotherapeutics Platform: Successful Demonstration of Dual Targeting With Duocalin(R) Technology
9. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
10. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
11. Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... CALGARY, Alberta , September 2, 2014 /PRNewswire/ ... "State of the Art and Featured Research Session" beim ... Corp. (TSX: RVX) gab heute bekannt, dass Dr. Jan Johansson, ... Kongress des europäischen Kardiologenverbandes (ESC) 2014 in ... seinem Vortrag mit dem Titel " Effects of RVX-208 ...
(Date:9/2/2014)... 2014  Ameritox SM , the nation,s leader in ... Drugs to Heroin," a research report that provides concrete ... examines deadly trends that have created a unique heroin ... The report is based on data ... It examines five trends that distinguish the heroin abuse ...
(Date:9/2/2014)... 2014   Santa Clara dentist , Dr. ... for Invisalign. Invisalign is an orthodontic system that uses ... often the orthodontic treatment of choice for older teens ... it. For a limited time, patients can try Invisalign ... the usual cost. This offer cannot be combined, and ...
Breaking Medicine Technology:RVX-208 führt bei Patienten mit Diabetes mellitus zu einer Verringerung des relativen Risikos von gravierenden unerwünschten Herzkreislaufereignissen um 77 % 2RVX-208 führt bei Patienten mit Diabetes mellitus zu einer Verringerung des relativen Risikos von gravierenden unerwünschten Herzkreislaufereignissen um 77 % 3RVX-208 führt bei Patienten mit Diabetes mellitus zu einer Verringerung des relativen Risikos von gravierenden unerwünschten Herzkreislaufereignissen um 77 % 4RVX-208 führt bei Patienten mit Diabetes mellitus zu einer Verringerung des relativen Risikos von gravierenden unerwünschten Herzkreislaufereignissen um 77 % 5RVX-208 führt bei Patienten mit Diabetes mellitus zu einer Verringerung des relativen Risikos von gravierenden unerwünschten Herzkreislaufereignissen um 77 % 6Ameritox Research Report Reveals Pain Patients' Role in Current Heroin Epidemic 2Santa Clara Cosmetic Dentist, Dr. Alan Frame, is Now Offering a Special on Invisalign 2
... February 1, 2011, the Massachusetts Institute of Technology (MIT) ... Engineering Systems Division will host the Innovation in ... from Discovery to Delivery at ... Pharmaceuticals, will be a forum to stimulate new ways ...
... Jan. 18, 2011 TechniScan (OTC Bulletin ... engaged in the development and commercialization of an automated ... has signed a Product Development Agreement with Austin, Texas ... TechniScan and Womens3D will co-develop technology ...
Cached Medicine Technology:Michael Porter, Janet Woodcock, Peter Senge Among Speakers at Inaugural Innovation in Healthcare Symposium 2Michael Porter, Janet Woodcock, Peter Senge Among Speakers at Inaugural Innovation in Healthcare Symposium 3Michael Porter, Janet Woodcock, Peter Senge Among Speakers at Inaugural Innovation in Healthcare Symposium 4Michael Porter, Janet Woodcock, Peter Senge Among Speakers at Inaugural Innovation in Healthcare Symposium 5Michael Porter, Janet Woodcock, Peter Senge Among Speakers at Inaugural Innovation in Healthcare Symposium 6Michael Porter, Janet Woodcock, Peter Senge Among Speakers at Inaugural Innovation in Healthcare Symposium 7Michael Porter, Janet Woodcock, Peter Senge Among Speakers at Inaugural Innovation in Healthcare Symposium 8TechniScan Signs Agreement With Texas-Based Company to Co-Develop A New Version of Its Breast Imaging Device 2TechniScan Signs Agreement With Texas-Based Company to Co-Develop A New Version of Its Breast Imaging Device 3
(Date:9/2/2014)... less intensive (and expensive) practice patterns appear to consistently ... unnecessary and excessive medical care, according to a new ... concern about the costs and harms of medical care ... the provision of unnecessary care," said lead author Brenda ... Institute for Health Policy & Clinical Practice. , ...
(Date:9/2/2014)... GA (PRWEB) September 02, 2014 Last year, ... new level with the launch of a luxurious line of ... announce that the SEA ISLAND COTTON Socks are joining the ... level, giving more people the comfort of natural cotton fibers. ... Socks, they are surprised to find socks as soft as ...
(Date:9/2/2014)... research shows a novel polypill increases patient adherence ... heart attack, according to new study results reported ... 2014 in Barcelona, Spain. According to Principal Investigator ... Heart at Icahn School of Medicine at Mount ... de Investigaciones Cardiovasculares Carlos III (CNIC) in Madrid, ...
(Date:9/2/2014)... September 02, 2014 For the eighth ... security and network services company, has been named one ... magazine's Inc. 5000 list highlights America's fastest growing companies. ... since the list inception in 2007. , Landing on ... 144 percent over the past three years. , “We ...
(Date:9/2/2014)... Cleveland, Ohio (PRWEB) September 02, 2014 ... Cellulon® Polyurethane technology to reduce discomfort and fatigue by ... flooring. Using an eco-friendly, renewable bio-foam core, these anti-fatigue ... in the USA. According to a study by the ... showing a significant difference in reducing spinal compression and ...
Breaking Medicine News(10 mins):Health News:Residency training predicts physicians' ability to practice conservatively 2Health News:SIGVARIS’ Luxury Line of Compression Socks, SEA ISLAND COTTON, Now Available in Stronger Compression Level 2Health News:New polypill increases heart attack patients' medication adherence 2Health News:New polypill increases heart attack patients' medication adherence 3Health News:CentraComm Named to Inc. 5000 for 8th Consecutive Year 2Health News:New Eco-Pro Premium Anti-fatigue Mats from Martinson-Nicholls Prevent Fatigue and Discomfort for Standing Workers 2
... N.C., Sept. 22 The North Carolina Dental Society (NCDS) has ... in dental health promotion to the public. , , ... dental association that most effectively improves awareness of oral health issues ... program associated with the North Carolina Missions of Mercy (NCMOM) free ...
... , Surgeons Urge Prompt Treatment for Growth ... Indoors and outdoors, youth athletes stay active year-round in competitive sports, and for ... The American College of Foot and Ankle Surgeons advises that when a child ... a warning sign of a serious foot problem. , ...
... HUNTINGTON BEACH, Calif., Sept. 22 The 5th Annual NAMIWalks Orange County ... Huntington Beach Pier. , , This Saturday ... National Alliance on Mental Illness - Orange County (NAMI-OC) and raise awareness ... serve the needs of local individuals and families affected by serious mental ...
... air outside is polluted, a new research report in the ... http://www.genetics.org ) might make you to think twice about the ... about 3 percent of the air we breathe gets converted ... superoxides lead to the creation of a toxic molecule called ...
... , , MINNEAPOLIS and ... help students and teachers stay healthy during this influenza season, ... of hand sanitizer to more than 120 Minneapolis and St. ... Children,s will provide informational newsletters in both English and Spanish ...
... , , Exercise ... Program , , ALEXANDRIA, ... counseling combined with fitness center-based exercise training can improve muscular ... with outcomes similar to those of supervised exercise, according to ...
Cached Medicine News:Health News:Heel Pain in Youth Athletes: A Warning Sign 2Health News:NAMI-OC 5K Walk Funds Free Mental Health Programs in Orange County 2Health News:New research provides new insight into age-related muscle decline 2Health News:Children's Hospitals and Clinics of Minnesota Launches H1N1 Outreach Effort with Minneapolis and Saint Paul Public Schools 2Health News:Children's Hospitals and Clinics of Minnesota Launches H1N1 Outreach Effort with Minneapolis and Saint Paul Public Schools 3Health News:Research: People With Type 2 Diabetes Improved Muscular Strength and Exercise Capacity Through Physical Therapist Exercise Counseling Combined With Fitness Center Exercise Training 2Health News:Research: People With Type 2 Diabetes Improved Muscular Strength and Exercise Capacity Through Physical Therapist Exercise Counseling Combined With Fitness Center Exercise Training 3
Quantitative Plasma-based Factor XIII Incorporation Assay Kit...
Assay for Determination of Initial Thrombin Formation...
Thrombin Activatable Fibrinolysis Inhibitor Assay Kit...
Pefakit PiCT LMWH Calibrators...
Medicine Products: